Claudin18.2-targeted Chimeric Antigen Receptor T cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Claudin18.2-targeted Chimeric Antigen Receptor T cells, covering 2024-04-30 to 2024-04-30. Get the full timeline:
Most recent: Clinical Trial Update: Chimeric Antigen Receptor T Cells Targeting claudin18.2 in Solid Tumors. [Phase 1]